1. Home
  2. NSSC vs NVAX Comparison

NSSC vs NVAX Comparison

Compare NSSC & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NAPCO Security Technologies Inc.

NSSC

NAPCO Security Technologies Inc.

HOLD

Current Price

$44.62

Market Cap

1.4B

ML Signal

HOLD

NVAX

Novavax Inc.

HOLD

Current Price

$10.30

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NSSC
NVAX
Founded
1969
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.5B
IPO Year
1994
1996

Fundamental Metrics

Financial Performance
Metric
NSSC
NVAX
Price
$44.62
$10.30
Analyst Decision
Strong Buy
Hold
Analyst Count
6
9
Target Price
$48.17
$11.33
AVG Volume (30 Days)
549.7K
4.1M
Earning Date
05-04-2026
05-20-2026
Dividend Yield
1.29%
N/A
EPS Growth
N/A
309.76
EPS
0.72
2.58
Revenue
$181,621,000.00
$1,123,479,000.00
Revenue This Year
$13.47
N/A
Revenue Next Year
$9.75
N/A
P/E Ratio
$64.26
$3.89
Revenue Growth
N/A
64.69
52 Week Low
$19.63
$5.01
52 Week High
$47.61
$11.85

Technical Indicators

Market Signals
Indicator
NSSC
NVAX
Relative Strength Index (RSI) 54.69 60.84
Support Level $41.96 $6.34
Resistance Level $47.61 $10.42
Average True Range (ATR) 1.69 0.69
MACD 0.11 0.13
Stochastic Oscillator 55.07 54.86

Price Performance

Historical Comparison
NSSC
NVAX

About NSSC NAPCO Security Technologies Inc.

NAPCO Security Technologies Inc manufactures security products, encompassing access control systems, door-locking products, intrusion and fire alarm systems and video surveillance products. Its products are used for various applications which includes alarm systems like automatic communicators, combination control panels/digital communicators and digital keypad systems, fire alarm control panel and area detectors mainly used for commercial, residential, institutional, industrial and governmental uses. Geographically, the company derives a majority of its revenue from the United States.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

Share on Social Networks: